stearoylethanolamide has been researched along with Encephalitis in 1 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 1 (100.00) | 2.80 |
| Authors | Studies |
|---|---|
| Heinemann, A; Hudz, YA; Kasatkina, LA; Sturm, EM; Thomas, D | 1 |
1 other study(ies) available for stearoylethanolamide and Encephalitis
| Article | Year |
|---|---|
Stearoylethanolamide interferes with retrograde endocannabinoid signalling and supports the blood-brain barrier integrity under acute systemic inflammation.
Topics: Animals; Blood-Brain Barrier; Disease Models, Animal; Encephalitis; Endocannabinoids; Inflammation; Lipopolysaccharides; Male; Mice; Mice, Inbred C57BL; Neurons; Neuroprotective Agents; Receptor, Cannabinoid, CB1; Receptor, Cannabinoid, CB2; Signal Transduction; Stearic Acids | 2020 |